Detection of Circulating Tumor DNA for Disease Monitoring in Patients with Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

J Invest Dermatol. 2024 Aug 21:S0022-202X(24)01996-1. doi: 10.1016/j.jid.2024.07.025. Online ahead of print.
No abstract available

Keywords: Disease monitoring; Liquid biopsy; MYD88; Minimal residual disease; Primary cutaneous diffuse large B-cell lymphoma; leg type.